Chiesi launches innovation platform focused on partnership and patient care: The Impulse

PARMA, Italy, Oct. 18, 2024 /PRNewswire/ — Chiesi Group, a research-oriented international biopharmaceutical group, is proud to announce the official launch of The Impulse, an innovation platform designed to accelerate bold ideas and meaningful partnerships in healthcare. The Impulse aims to tackle some of the biggest challenges facing patients, planet, and people today by addressing not only healthcare symptoms but also the root causes of these challenges, such as climate change and access to care.

Empowering innovation through collaboration

The Impulse is stepping in to fill the growing demand for innovative solutions that meet the real needs of patients. By creating a collaborative space for researchers, start-ups, and innovators to work together, The Impulse is driving forward-thinking healthcare solutions—from digital health advancements to sustainable patient care models—that have the potential to transform how we think about and deliver healthcare.

“We stand at a pivotal moment for the pharmaceutical industry. This is the time to further rethink traditional models and embrace bolder, patient-centric innovation. That’s why Chiesi has created The Impulse, aiming to empower those who are driven by a passion to improve the lives of others through innovation,” said Fabrizio Conicella, Vice-President Center of Open Innovation & Competence. “We know that some of the most groundbreaking ideas come from collaboration. By providing the resources, network, and support, we aim to accelerate ideas that will have a tangible impact on patients and the world around us, perfectly in line with our Company vision.”

A commitment to patients and the planet

The launch of The Impulse is particularly timely, as the healthcare industry faces increasing pressure to rethink traditional care models. With climate change and environmental sustainability now central to global health discussions, The Impulse is committed to fostering solutions that not only improve patient outcomes but also contribute to a healthier planet.

The Impulse has already begun to attract interest from key players in the life sciences, digital health, and environmental sustainability sectors, including the Karolinska Institutet, NOME and EIT-HEALTH, with many more partnerships in the pipeline.

For more information on The Impulse and how to get involved, visit https://www.chiesi.com/en/about-us/the-impulse/.

View original content:https://www.prnewswire.com/news-releases/chiesi-launches-innovation-platform-focused-on-partnership-and-patient-care-the-impulse-302279551.html

SOURCE Chiesi

Staff

Recent Posts

Health Care AI Initiative Launched by Paragon Health Institute

New initiative will promote AI policies and solutions to transform American health careWASHINGTON, Jan. 12,…

27 minutes ago

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions RANCHO CUCAMONGA, CA…

27 minutes ago

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…

3 hours ago

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

4 hours ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

18 hours ago